Publications

Chandra A, Sharma A, Calingasan NY, White JM, Shurubor Y, X Yang W, M Beal F, Johri A.  2016.  Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.. Hum Mol Genet. 25(11):2269-2282.

Esmaeili MA, Yadav S, Gupta RKr, Waggoner GR, DeLoach A, Calingasan NY, M Beal F, Kiaei M.  2016.  Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo.. Hum Mol Genet. 25(2):317-27.

Shurubor YI, D'Aurelio M, Clark-Matott J, Isakova EP, Deryabina YI, M Beal F, Cooper AJL, Krasnikov BF.  2017.  Determination of Coenzyme A and Acetyl-Coenzyme A in Biological Samples Using HPLC with UV Detection.. Molecules. 22(9)

Ranea-Robles P, Launay N, Ruiz M, Calingasan NYlagan, Dumont M, Naudí A, Portero-Otín M, Pamplona R, Ferrer I, M Beal F et al..  2018.  Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.. EMBO Mol Med.

Bose A, M Beal F.  2018.  Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson's disease.. Eur J Neurosci.

Chen Q, Kirk K, Shurubor YI, Zhao D, Arreguin AJ, Shahi I, Valsecchi F, Primiano G, Calder EL, Carelli V et al..  2018.  Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations.. Cell Metab.

Lloret A, M Beal F.  2019.  PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.. Neurochem Res.